• Investors
  • News
  • Contact
Iconovo
  • About us
    • Board of Directors
    • Management
    • Our Team
    • Sustainability
    • Career
  • Products
    • Products
    • ICOres
    • ICOcap
    • ICOpre
    • ICOone
    • ICOone Nasal
    • Patents
  • Capabilities
    • Capabilities
    • Devices
    • Formulation
    • Characterization
    • General Support
  • Collaborations
  • Insights
    • Meet us at CPHI 2022
    • Replacing injections with inhalation
    • Boost your business with an innovative inhaler partner
  • Search
  • Menu Menu
  • LinkedIn
  • Twitter

Replacing injections with inhalation

Boost your business with an innovative inhaler partner

There is a growing interest in delivering drugs by inhalation, not only medicines that treat the lungs and airways – such as those against asthma and chronic obstructive pulmonary disease (COPD), but also drugs that acts systemically. Vaccines, for instance, can be given as inhalation instead of injection. Inhaled vaccine will activate immune cells in the mucosal tissue, which will act more quickly than the immune response after an intramuscular injection. Iconovo has the knowledge, experience, and capabilities to develop pharmaceuticals previously administered by injection into new inhalation products.

Replacing injections with inhalation

There are many therapies given as injections, that are temperature sensitive and challenging to store and transport, for example insulin and vaccines. One of the major challenges in vaccination programs in low-income regions with poor infrastructure, is the need of a cold chain for transportation of the vaccine.

Learn more

Improved performance with inhalation

When you think of inhaled medicine, you often think of treatments for asthma, COPD and other conditions in the lungs and airways. Today, there is a growing interest in inhalation as a route of administration for other therapeutic areas well.

Learn more

Inhalation made easy with ICOone

There is a growing interest in delivering drugs by inhalation, not only medicines that treat the lungs and airways – such as those against asthma and chronic obstructive pulmonary disease (COPD), but also drugs that acts systemically.

Learn more

ARTICLE

Insulin delivered with inhaler – the case strengthens

Fill in the form to get to the download page.

Your email-address is safe with us, we will not spam you. You will receive 4 newsletters per year with relevant news on inhaled medicine. Enjoy the white paper and feel free to reach out to us.

    Want to be up to date with with our platforms and news in inhalation?

    Sign up for our newsletters now!

    You can trust us with your email-address. We will send you four newsletters per year with news on our platforms. No more, no less.

    Possessing a unique combination

    of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.

    ICONOVO AB

    VISITING ADDRESS
    Ideon, Delta 6 Lund
    Ideongatan 3B

    POSTAL ADDRESS
    Iconovo AB
    Ideongatan 3A-B
    SE-223 70 LUND
    Sweden

    CONTACT

    Phone: +46 46 275 67 77

    VP Business Development
    Roger Lassing
    Mail: roger.lassing@iconovo.se

    CEO
    Johan Wäborg
    Mail: johan.waborg@iconovo.se

    SITEMAP

    • Home
    • Capabilities
    • Investors

    Press releases

    Subscribe

    Follow us on Linkedin

    Scroll to top